Inhibiting Rac1 activity (Rac1 mutant construct) inhibits the growth of mutant K-RAS human pancreatic cancer cells but not pancreatic cancer cells with wild-type K-RAS [83] in a superoxide-dependent manner. This evidence concerns the gene KRAS and pancreatic neoplasm.